Neosporin market share north america otc antibiotic ointment 30%?

I can help, but I need one clarification because your phrasing (“Neosporin market share north america OTC antibiotic ointment 30%”) could mean either:

1. You’re asking whether Neosporin has ~30% market share in North America for OTC antibiotic ointments, or
2. You’re telling me market share is 30% and want sources/verification.

What I can do

• If you want the most accurate market-share figure, I can point you to the right market research reports—but those numbers are usually paywalled (e.g., IQVIA, Circana/IRI, SPINS/NielsenIQ, GlobalData, Euromonitor, etc.).
• If you’re okay with directional/approximate info, I can summarize likely competitive positioning qualitatively (Neosporin vs. Bacitracin/polymyxin generics, store brands, etc.), but that won’t be as exact as a cited “30%” claim.

Quick context (why the “30%” may be hard to confirm)

OTC antibiotic ointments are often reported under narrow categories (e.g., “topical antibiotic first aid,” “antibiotic ointments,” “triple antibiotic” vs broader “wound care antiseptics”). Market share depends heavily on:

• Exact product definition (e.g., triple-antibiotic ointment vs any topical antibiotic)
• Channel (mass, grocery, drugstore, online)
• Units vs dollars (and whether generics are included)

To proceed, tell me:

1. Do you want Neosporin’s exact market share % (and whether it’s units or dollars)?
2. Which source do you have in mind (or where did “30%” come from)?
3. Are you looking specifically at “triple antibiotic ointment” (Neosporin class) or a broader OTC topical antibiotic/wound care category?

If you reply with those details (and ideally the report title/link if you have it), I can help you confirm or contextualize the 30% number and point to the most relevant supporting sources.